A detailed history of Securian Asset Management, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 140,196 shares of MRK stock, worth $13.8 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
140,196
Previous 145,638 3.74%
Holding current value
$13.8 Million
Previous $18 Million 11.7%
% of portfolio
0.46%
Previous 0.53%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $604,878 - $701,854
-5,442 Reduced 3.74%
140,196 $15.9 Million
Q2 2024

Jul 15, 2024

SELL
$123.8 - $132.96 $447,413 - $480,517
-3,614 Reduced 2.42%
145,638 $18 Million
Q1 2024

Apr 26, 2024

SELL
$113.24 - $131.95 $1.27 Million - $1.48 Million
-11,236 Reduced 7.0%
149,252 $19.7 Million
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $2.16 Million - $2.36 Million
-21,609 Reduced 11.87%
160,488 $17.5 Million
Q3 2023

Oct 30, 2023

SELL
$102.95 - $114.33 $3.18 Million - $3.53 Million
-30,911 Reduced 14.51%
182,097 $18.7 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $241,005 - $262,685
-2,219 Reduced 1.03%
213,008 $24.6 Million
Q1 2023

Apr 27, 2023

BUY
$102.94 - $114.86 $91,513 - $102,110
889 Added 0.41%
215,227 $22.9 Million
Q4 2022

Feb 02, 2023

BUY
$87.44 - $112.11 $690,863 - $885,781
7,901 Added 3.83%
214,338 $23.8 Million
Q3 2022

Oct 28, 2022

BUY
$84.53 - $94.96 $118,342 - $132,944
1,400 Added 0.68%
206,437 $17.8 Million
Q2 2022

Aug 04, 2022

SELL
$83.49 - $94.64 $75,307 - $85,365
-902 Reduced 0.44%
205,037 $18.7 Million
Q1 2022

May 03, 2022

SELL
$73.51 - $82.4 $205,754 - $230,637
-2,799 Reduced 1.34%
205,939 $16.9 Million
Q4 2021

Feb 10, 2022

SELL
$72.28 - $90.54 $462,592 - $579,456
-6,400 Reduced 2.97%
208,738 $16 Million
Q3 2021

Nov 08, 2021

SELL
$71.68 - $78.83 $173,035 - $190,295
-2,414 Reduced 1.11%
215,138 $16.2 Million
Q2 2021

Aug 10, 2021

SELL
$70.31 - $77.77 $75,653 - $83,680
-1,076 Reduced 0.49%
217,552 $16.9 Million
Q1 2021

May 10, 2021

SELL
$68.86 - $81.11 $498,959 - $587,723
-7,246 Reduced 3.21%
218,628 $16.9 Million
Q4 2020

Feb 08, 2021

SELL
$71.77 - $79.65 $482,150 - $535,088
-6,718 Reduced 2.89%
225,874 $18.5 Million
Q3 2020

Nov 04, 2020

SELL
$73.18 - $82.95 $186,609 - $211,522
-2,550 Reduced 1.08%
232,592 $19.3 Million
Q2 2020

Aug 06, 2020

SELL
$70.42 - $80.13 $1.2 Million - $1.36 Million
-17,017 Reduced 6.75%
235,142 $18.2 Million
Q1 2020

May 07, 2020

SELL
$63.36 - $87.82 $276,186 - $382,807
-4,359 Reduced 1.7%
252,159 $19.4 Million
Q4 2019

Feb 04, 2020

SELL
$77.58 - $87.54 $862,922 - $973,707
-11,123 Reduced 4.16%
256,518 $23.3 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $278,985 - $304,104
-3,667 Reduced 1.35%
267,641 $22.5 Million
Q2 2019

Aug 05, 2019

BUY
$69.84 - $81.59 $103,502 - $120,916
1,482 Added 0.55%
271,308 $22.7 Million
Q1 2019

Apr 26, 2019

SELL
$69.58 - $79.36 $5,009 - $5,713
-72 Reduced 0.03%
269,826 $22.4 Million
Q4 2018

Feb 04, 2019

SELL
$65.24 - $75.71 $53,627 - $62,233
-822 Reduced 0.3%
269,898 $20.6 Million
Q3 2018

Oct 26, 2018

SELL
$57.69 - $67.84 $174,973 - $205,758
-3,033 Reduced 1.11%
270,720 $19.2 Million
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $27,194 - $31,950
535 Added 0.2%
273,753 $16.6 Million
Q1 2018

Apr 30, 2018

SELL
$50.96 - $59.23 $225,905 - $262,566
-4,433 Reduced 1.6%
273,218 $14.9 Million
Q4 2017

Feb 05, 2018

BUY
$51.62 - $61.64 $31,952 - $38,155
619 Added 0.22%
277,651 $15.6 Million
Q3 2017

Nov 03, 2017

BUY
$58.67 - $63.13 $59,080 - $63,571
1,007 Added 0.36%
277,032 $17.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
276,025
276,025 $17.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Securian Asset Management, Inc Portfolio

Follow Securian Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.